TECH
Bio-Techne·NASDAQ
--
--(--)
--
--(--)
TECH fundamentals
Bio-Techne (TECH) Revenue Breakdown: Q2 2026 Business & Regional Performance
Bio-Techne (TECH) reported total revenue of 295.88M USD in Q2 2026, with its core business segment Protein Sciences contributing 72.69%. Regionally, United States remained the largest market, accounting for 49.53% of total revenue. Explore Bio-Techne's revenue distribution across business segments and global markets to gain insights into its growth trends and market position.
Bio-Techne (TECH) reported total revenue of 295.88M USD in Q2 2026, with its core business segment Protein Sciences contributing 72.69%. Regionally, United States remained the largest market, accounting for 49.53% of total revenue. Explore Bio-Techne's revenue distribution across business segments and global markets to gain insights into its growth trends and market position.
By Business
No Data
By Region
No Data
You can ask Aime
What is the market's earnings forecast for Bio-Techne next quarter?What is Bio-Techne's gross profit margin?What is Bio-Techne's latest dividend and current dividend yield?What does Bio-Techne do and what are its main business segments?What is the revenue and EPS growth rate for Bio-Techne year over year?What were the key takeaways from Bio-Techne's earnings call?What factors drove the changes in Bio-Techne's revenue and profit?Did Bio-Techne beat or miss consensus estimates last quarter?
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
